ARCUTIS BIOTHERAPEUTIC
10.15
20-September-24 15:59:59
15 minutes delayed
Stocks
+0.01
+0.10%
Today's range
9.78 - 10.31
ISIN
N/A
Source
NASDAQ
-
Arcutis Biotherapeutics Announces Proposed Public Offering of Common Stock
02 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
29 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
11 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2022 16:04:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jun 2022 16:16:00 By Nasdaq GlobeNewswire
-
25 May 2022 10:33:12 By Nasdaq GlobeNewswire
-
25 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Announces First Quarter 2022 Financial Results and Provides Business Update
05 May 2022 16:01:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 May 2022 08:00:04 By Nasdaq GlobeNewswire
-
06 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Highlights Growth Opportunities at Investor Day in Advance of 2022 Catalysts
28 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
25 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
25 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
22 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
Arcutis to Host Investor Day on March 28
21 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
02 Mar 2022 05:30:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
22 Feb 2022 16:01:00 By Nasdaq GlobeNewswire
-
01 Feb 2022 08:00:01 By Nasdaq GlobeNewswire